Swept-Source Optical Coherence Tomography Thresholds in Differentiating Clinical Outcomes in a Real-World Cohort of Treatment-Naive Multiple Sclerosis Patients

被引:0
作者
Rzepinski, Lukasz [1 ,2 ]
Kucharczuk, Jan [3 ]
Tkaczynska, Magda [4 ]
Parisi, Vincenzo [5 ]
Grzybowski, Andrzej [6 ,7 ]
机构
[1] 10th Mil Res Hosp & Polyclin, Dept Neurol, Powstancow Warszawy 5, PL-85681 Bydgoszcz, Poland
[2] Sanitas Neurol Outpatient Clin, Dworcowa 110, PL-85010 Bydgoszcz, Poland
[3] 10th Mil Res Hosp & Polyclin, Dept Ophthalmol, Powstancow Warszawy 5, PL-85681 Bydgoszcz, Poland
[4] 10th Mil Res Hosp & Polyclin, Dept Surg, Powstancow Warszawy 5, PL-85681 Bydgoszcz, Poland
[5] IRCCS Fdn Bietti, Via Livenza 3, I-00198 Rome, Italy
[6] Univ Warmia & Mazury, Dept Ophthalmol, Zolnierska 18, PL-10561 Olsztyn, Poland
[7] Fdn Ophthalmol Dev, Inst Res Ophthalmol, Mickiewicza 24-3B, PL-60836 Poznan, Poland
关键词
multiple sclerosis; optical coherence tomography; GCIPL; pRNFL; disability progression; DIAGNOSIS; ATROPHY; OCT;
D O I
10.3390/brainsci13040591
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aimed to determine whether peripapillary retinal nerve fiber layer (pRNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness thresholds for single-time-point swept-source optical coherence tomography (SS-OCT) measures can differentiate the clinical outcomes of treatment-naive people with multiple sclerosis (pwMS). A total of 275 patients with the clinically isolated syndrome (n = 23), benign MS (n = 8), relapsing-remitting MS (n = 185), secondary progressive MS (n = 28), primary progressive MS (n = 31), and with no history of optic neuritis were included. The mean Expanded Disability Status Scale (EDSS) score was 3.0 +/- 1.6. The cut-off values of pRNFL (87 mu m and 88 mu m) and GCIPL (70 mu m) thicknesses have been adopted from previous studies using spectral-domain OCT. PwMS with pRNFL <= 87 mu m and <= 88 mu m had a longer disease duration, more advanced disability, and more frequently progressive MS variants compared to those with greater pRNFL thicknesses. In distinguishing pwMS with disability greater than or equal to the mean EDSS score (EDSS >= 3) from those with less severe disability, GCIPL thickness <70 mu m had the highest sensitivity, while pRNFL thickness <= 87 mu m had the greatest specificity. The optimal cut-off values differentiating patients with EDSS >= 3 from those with less severe disability was 63 mu m for GCIPL thickness and 93.5 mu m for pRNFL thickness. In conclusion, pRNFL and GCIPL thickness thresholds for single-time-point SS-OCT measurements may be helpful in differentiating the disability status of treatment-naive pwMS.
引用
收藏
页数:13
相关论文
共 43 条
[1]   Mechanisms underlying progression in multiple sclerosis [J].
Absinta, Martina ;
Lassmann, Hans ;
Trapp, Bruce D. .
CURRENT OPINION IN NEUROLOGY, 2020, 33 (03) :277-285
[2]  
[Anonymous], NEUROSTATUS
[3]   Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis [J].
Britze, Josefine ;
Pihl-Jensen, Gorm ;
Frederiksen, Jette Lautrup .
JOURNAL OF NEUROLOGY, 2017, 264 (09) :1837-1853
[4]   Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis [J].
Bsteh, Gabriel ;
Hegen, Harald ;
Altmann, Patrick ;
Auer, Michael ;
Berek, Klaus ;
Di Pauli, Franziska ;
Leutmezer, Fritz ;
Rommer, Paulus ;
Wurth, Sebastian ;
Zinganell, Anne ;
Zrzavy, Tobias ;
Deisenhammer, Florian ;
Berger, Thomas .
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (06) :2037-2045
[5]   Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis [J].
Bsteh, Gabriel ;
Berek, Klaus ;
Hegen, Harald ;
Altmann, Patrick ;
Wurth, Sebastian ;
Auer, Michael ;
Zinganell, Anne ;
Di Pauli, Franziska ;
Rommer, Paulus ;
Leutmezer, Fritz ;
Deisenhammer, Florian ;
Berger, Thomas .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) :684-694
[6]   Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis [J].
Bsteh, Gabriel ;
Hegen, Harald ;
Teuchner, Barbara ;
Amprosi, Matthias ;
Berek, Klaus ;
Ladstaetter, Felix ;
Wurth, Sebastian ;
Auer, Michael ;
Di Pauli, Franziska ;
Deisenhammer, Florian ;
Berger, Thomas .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (02) :196-203
[7]   Disease-modifying therapies modulate retinal atrophy in multiple sclerosis A retrospective study [J].
Button, Julia ;
Al-Louzi, Omar ;
Lang, Andrew ;
Bhargava, Pavan ;
Newsome, Scott D. ;
Frohman, Teresa ;
Balcer, Laura J. ;
Frohman, Elliot M. ;
Prince, Jerry ;
Calabresi, Peter A. ;
Saidha, Shiv .
NEUROLOGY, 2017, 88 (06) :525-532
[8]   Reproducibility of optical coherence tomography in multiple sclerosis [J].
Cettomai, Deanna ;
Pulicken, Mathew ;
Gordon-Lipkin, Eliza ;
Salter, Amber ;
Frohman, Teresa C. ;
Conger, Amy ;
Zhang, Xiao ;
Cutter, Gary ;
Balcer, Laura J. ;
Frohman, Elliot M. ;
Calabresi, Peter A. .
ARCHIVES OF NEUROLOGY, 2008, 65 (09) :1218-1222
[9]   Secondary Progressive Multiple Sclerosis New Insights [J].
Cree, Bruce A. C. ;
Arnold, Douglas L. ;
Chataway, Jeremy ;
Chitnis, Tanuja ;
Fox, Robert J. ;
Ramajo, Angela Pozo ;
Murphy, Niamh ;
Lassmann, Hans .
NEUROLOGY, 2021, 97 (08) :378-388
[10]   The APOSTEL recommendations for reporting quantitative optical coherence tomography studies [J].
Cruz-Herranz, Andres ;
Balk, Lisanne J. ;
Oberwahrenbrock, Timm ;
Saidha, Shiv ;
Martinez-Lapiscina, Elena H. ;
Lagreze, Wolf A. ;
Schuman, Joel S. ;
Villoslada, Pablo ;
Calabresi, Peter ;
Balcer, Laura ;
Petzold, Axel ;
Green, Ari J. ;
Paul, Friedemann ;
Brandt, Alexander U. ;
Albrecht, Philipp .
NEUROLOGY, 2016, 86 (24) :2303-2309